OREX up +25.19% percent Today $OREX High is at 4.79 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2014 at 2:53 PM

OREX up +25.19% percent Today $OREX High is at 4.79 and the Low 4.04 with current volume of 4,685,142.

Recent News posted below.

Orexigen Therapeutics OREX other info.
http://investorshangout.com/Orexigen-Therapeu...REX-55007/

OREX Orexigen Therapeutics Recent Headline News

Arena And Vivus Investors Need To Watch Orexigen
Spencer Osborne - at Seeking Alpha - 1 hr 28 mins ago

OREX: 5.08 (+1.23), VVUS: 3.23 (-0.10), ARNA: 4.34 (+0.08)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - 1 hr 52 mins ago

UCP: 11.82 (-1.97), JRJC: 6.21 (+0.70), NAVB: 1.03 (-0.19), SANW: 3.76 (+0.68), PLPM: 1.63 (+0.26), RYN: 28.62 (-5.28), INFU: 3.02 (-0.47), LIOX: 5.49 (+0.75), DY: 27.75 (-3.12), MTZ: 25.31 (-3.32), CGIX: 6.92 (+0.92), MUX: 1.25 (-0.16), OREX: 5.08 (+1.23), URRE: 2.54 (+0.60), ACHN: 12.54 (+2.43), REN: 2.83 (-0.78), MPO: 3.33 (+0.22), AKBA: 9.28 (-1.42), TRX: 1.02 (-0.20), PLNR: 7.53 (+1.13)

Stock to Watch: Orexigen Therapeutics Up 19.5% (OREX)
Comtex SmarTrend(R) - 2 hrs 25 mins ago
Orexigen Therapeutics (NASDAQ:OREX) is one of today's best performing low-priced stocks, up 19.5% to $4.60 on 1.1x average daily volume. Orexigen Therapeutics has traded 3.6 million shares thus far today, vs. average volume of 3.3 million shares per day. The stock has outperformed the Dow (19.5% to the Dow's 0.1%) and outperformed the S&P 500 (19.5% to the S&P's 0.3%) during today's trading.
OREX: 5.08 (+1.23)

Orexigen Therapeutics' (OREX) CEO Mike Narachi on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 10:51AM CST

OREX: 5.08 (+1.23)

Orexigen ups earnings by 161% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 10:16AM CST

OREX: 5.08 (+1.23)

Orexigen rises as weight loss drug review proceeds
AP - Mon Nov 10, 10:02AM CST
NEW YORK (AP) — Shares of Orexigen Therapeutics Inc. jumped Monday after the company said a European Union review of its weight loss drug Contrave, which was approved in the U.S. in September, is progressing on schedule.
OREX: 5.08 (+1.23), VVUS: 3.23 (-0.10), ARNA: 4.34 (+0.08)

Orexigen Therapeutics (OREX) Stock Soars Today on Big Third Quarter Earnings Beat
at The Street - Mon Nov 10, 9:33AM CST
Orexigen Therapeutics (OREX) stock is skyrocketing this morning after the company posted higher than expected third quarter earnings.
OREX: 5.08 (+1.23)

Orexigen Beats The Street On Milestone Payments
Spencer Osborne - at Seeking Alpha - Mon Nov 10, 8:21AM CST

OREX: 5.08 (+1.23)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 8:14AM CST

PT: 1.63 (+0.11), GPRO: 76.08 (-2.98), OREX: 5.08 (+1.23), GOGO: 18.04 (+1.40), JRJC: 6.21 (+0.70), UEC: 1.87 (+0.15), ACHN: 12.54 (+2.43), ARQL: 1.16 (+0.10), CMCM: 20.50 (+0.30), IBIO: 1.24 (+0.08), DF: 16.31 (+1.89)

Orexigen Therapeutics (OREX) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 7:25AM CST

OREX: 5.08 (+1.23)

Orexigen Therapeutics beats by $0.22, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 6:08AM CST

OREX: 5.08 (+1.23)

Orexigen Therapeutics Reports Results for the Third Quarter Ended September 30, 2014
PR Newswire - Mon Nov 10, 6:00AM CST
Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced results for the third quarter ended September 30, 2014.
OREX: 5.08 (+1.23)

Critical Alerts For Stratasys, Orexigen Therapeutics, YY, Workday and Hong Kong Television Network Released By InvestorsObserver
PR Newswire - Fri Nov 07, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for SSYS, OREX, YY, WDAY and HKTV.
OREX: 5.08 (+1.23), YY: 81.94 (+2.44), WDAY: 95.33 (+0.77), SSYS: 104.40 (+1.33), HKTV: 11.08 (+0.21)

Orexigen Therapeutics to Present at the Credit Suisse Healthcare Conference
PR Newswire - Thu Nov 06, 3:30PM CST
Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the Credit Suisse Healthcare Conference in Phoenix. The presentation is scheduled for Tuesday, November 11th at 2:00 p.m. Mountain Time. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.
OREX: 5.08 (+1.23)

Vivus Beats The Street On Milestone Payment For ED Drug
Spencer Osborne - at Seeking Alpha - Thu Nov 06, 7:59AM CST

OREX: 5.08 (+1.23), VVUS: 3.23 (-0.10), ARNA: 4.34 (+0.08)

Orexigen Therapeutics to Host Third Quarter 2014 Financial Results Conference Call and Webcast
PR Newswire - Tue Nov 04, 3:15PM CST
Orexigen® Therapeutics, Inc. (Nasdaq: OREX) will announce financial results for the third quarter 2014, on Monday, November 10, 2014 before markets open. The announcement will be followed by a live webcast and conference call at 8:30 a.m. Eastern time (5:30 a.m. Pacific time).
OREX: 5.07 (+1.22)

Orexigen's Contrave Has Modest Start
Spencer Osborne - at Seeking Alpha - Mon Nov 03, 12:30PM CST

OREX: 5.07 (+1.22), ARNA: 4.34 (+0.08)

Orexigen Announces Contrave® (naltrexone HCI and bupropion HCI extended release) Data Presentations at the ObesityWeek Meeting in Boston
PR Newswire - Fri Oct 31, 7:30AM CDT
Orexigen Therapeutics (NASDAQ: OREX) today announced three Contrave® (naltrexone HCI and bupropion HCI) and two disease awareness abstracts have been accepted for poster presentations at the upcoming ObesityWeek meeting. This meeting will be held November 2-7, 2014 in Boston at the Boston Convention and Exposition Center.
OREX: 5.07 (+1.22)

Orexigen Therapeutics Has Substantial Upside For Bull Investors
L&F Capital Management - at Seeking Alpha - Wed Oct 29, 7:27AM CDT

OREX: 5.07 (+1.22)

Arena Skimps on Data Disclosure From Weight-Loss Combo Study
at The Street - Wed Oct 29, 6:30AM CDT
Arena Pharmaceuticals provided very little useful information Tuesday night about the Belviq-phentermine weight-loss combination.
OREX: 5.07 (+1.22), ARNA: 4.34 (+0.08)

Orexigen Therapeutics (OREXQ) Stock Research Links

OREXQ Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BOC Group's Challenger Role Eye-Opener in Gartner Quadrant

Cracking the Challenger Code: BOC Group's Debut Ever heard of BOC Group? If you haven’t, it’s time to pay attention. This Dublin-based outfit just muscled its way into the Challenger Quadrant of the 2026 Gartner Magic Quadrant for Digital Twin of an Organization Platforms. Not bad for its first trip to the dance. When a company crashes the scene like this, eyebrows...

ADA Audit Reveals Gaps in Event Management at 2026 Session

Hold onto your hats, folks, because the American Diabetes Association (ADA) just dropped a bombshell report with findings that'll make your head spin if you're keyed into the healthcare sector. They’ve wrapped this up in a bow of accountability, but let's dig into the crux of it. Behind the Controversy: The New Orleans Incident This all harks back to an incident on June...

Wheaton Precious Metals Sets 2026 Investor Day Webcast

Ready for a Glimpse into Wheaton's Strategy? Gather 'round, folks, because on September 16, 2026, Wheaton Precious Metals is rolling out the carpet for its Investor Day webcast. It's more than a routine session; it's an open window into what's simmering behind Wheaton's illustrious streams of gold and silver. I mean, what's better than having a front-row seat to the...

Grants Strengthen Future Skills in Culinary Education

Irons are heating up on the griddle of education as The Rachael Ray Foundation teams up with the National Restaurant Association Educational Foundation over a piping hot new initiative. They’re offering up $5,000 grants aimed squarely at bolstering high school culinary education. It's not every day you see such direct support for the next generation of culinary...

Axjo Group Expands in France with Eco-Tourets Buy

Seizing the French Market: Axjo's Strategic Play Every now and then, you come across a company that's not just talking the talk but walking the green walk. Axjo Group's latest move—scooping up France's Eco-Tourets—puts them squarely in that league. It ain't just about expanding the footprint; it's about owning a piece of the future where sustainability isn't a...

L.L.Bean Teams with Drake and Ann Michael Maye

The New Faces of L.L.Bean's Tradition Ah, here we go again with L.L.Bean, spicing things up with a bit of southern flair. This time they've reeled in the Mayes—Drake, that hotshot quarterback from the Patriots, and his better half, Ann Michael. A surprise duo, sure, but that's the kind of refresh the century-old brand could use. They’re all about making New England...

Ontario Airport Taps New Leadership Amid Growth Surge

Fresh Faces at Ontario International’s Helm Ever find yourself wandering into the airport too early for a flight, soaking in its quiet buzz as planes rev up on the tarmac? Well, at Ontario International, there’s a new wrinkle in that familiar scene. Ontario International Airport Authority (OIAA) has shuffled its leadership deck, plucking Dr. Ronald O. Loveridge as the...

MacGregor's Bold Play: RoRo Tech for TT-Line's Ferries

A Green Wave in the Baltic It looks like MacGregor's betting big on the future of maritime transport, and they're putting their chips down on TT-Line's next-gen battery-hybrid LNG ferries. With a contract fresh out of the oven, they've signed up to kit out these eco-warriors with a range of RoRo equipment. And let me tell you, this is no piddly order—by any stretch,...

Nozomi Networks: Leading OT Security in 2026

One Year of Massive Wins for Nozomi Networks Here's a wild trajectory: Nozomi Networks has been firing on all cylinders in 2026, capturing attention not just from analysts but also from anyone with a stake in the security game. The company’s impressive run was highlighted most recently when they were crowned a Leader in The Forrester Wave: Operational Technology...

Common Threads Takes Nutrition Education Digital in 2026

Digitizing 23 Years of Nutrition Know-How Common Threads has been in the trenches for over two decades, teaching kids and families how to eat right and cook healthier meals. Now, the nonprofit's dragging its vast experience into the digital realm, rolling out a beefed-up version of its TEACH platform this September 15th. Through new certificate courses in Nutrition...